Alpha-9 Oncology Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
47
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$175M
- Investors
-
17
Alpha-9 Oncology General Information
Description
Operator of a radiopharmaceutical company intended to improve the diagnosis and treatment of metastatic cancer. The company develops imaging and therapeutic molecules for solid and hematologic malignancies by using proprietary technology, enabling healthcare professionals to give patients differentiated molecules with the potential to extend their lives with favorable safety profiles.
Contact Information
Website
www.a9oncology.comCorporate Office
- 185 Dartmouth Street
- 6th Floor
- Boston, MA 02116
- United States
Corporate Office
- 185 Dartmouth Street
- 6th Floor
- Boston, MA 02116
- United States
Alpha-9 Oncology Timeline
Alpha-9 Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 23-Oct-2024 | $175M | Completed | Pre-Clinical Trials | ||
| 4. Early Stage VC (Series B) | 30-Jun-2022 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series A) | 28-Apr-2021 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 30-Jun-2020 | $77K | $77K | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Alpha-9 Oncology Comparisons
Industry
Financing
Details
Alpha-9 Oncology Competitors (15)
One of Alpha-9 Oncology’s 15 competitors is Leukos Biotech, a Venture Capital-Backed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Leukos Biotech | Venture Capital-Backed | Barcelona, Spain | ||||
| Sermonix Pharmaceuticals | Venture Capital-Backed | Columbus, OH | ||||
| Navidea Biopharmaceuticals | Corporation | Dublin, OH | ||||
| RadioMedix | Venture Capital-Backed | Houston, TX | ||||
| AsherBio | Venture Capital-Backed | South San Francisco, CA |
Alpha-9 Oncology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alpha-9 Oncology Patents
Alpha-9 Oncology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023257191-A1 | Cxcr4-targeting compounds, and methods of making and using the same | Pending | 20-Apr-2022 | ||
| EP-4511384-A1 | Cxcr4-targeting compounds, and methods of making and using the same | Pending | 20-Apr-2022 | ||
| CA-3201655-A1 | Radiolabeled compounds targeting the prostate-specific membrane antigen | Pending | 16-Dec-2020 | ||
| EP-4263509-A1 | Radiolabeled compounds targeting the prostate-specific membrane antigen | Pending | 16-Dec-2020 | ||
| US-20240018110-A1 | Radiolabeled compounds targeting the prostate-specific membrane antigen | Pending | 16-Dec-2020 | C07D257/02 |
Alpha-9 Oncology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alpha-9 Oncology Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aberdeen | Asset Manager | Minority | ||
| Andreessen Horowitz | Venture Capital | Minority | ||
| Ascenta Capital | Venture Capital | Minority | ||
| Delos Capital Partners | Venture Capital | Minority | ||
| Digitalis Ventures | Venture Capital | Minority |
Alpha-9 Oncology FAQs
-
When was Alpha-9 Oncology founded?
Alpha-9 Oncology was founded in 2018.
-
Where is Alpha-9 Oncology headquartered?
Alpha-9 Oncology is headquartered in Boston, MA.
-
What is the size of Alpha-9 Oncology?
Alpha-9 Oncology has 47 total employees.
-
What industry is Alpha-9 Oncology in?
Alpha-9 Oncology’s primary industry is Biotechnology.
-
Is Alpha-9 Oncology a private or public company?
Alpha-9 Oncology is a Private company.
-
What is Alpha-9 Oncology’s current revenue?
The current revenue for Alpha-9 Oncology is .
-
How much funding has Alpha-9 Oncology raised over time?
Alpha-9 Oncology has raised $261M.
-
Who are Alpha-9 Oncology’s investors?
Aberdeen, Andreessen Horowitz, Ascenta Capital, Delos Capital Partners, and Digitalis Ventures are 5 of 17 investors who have invested in Alpha-9 Oncology.
-
Who are Alpha-9 Oncology’s competitors?
Leukos Biotech, Sermonix Pharmaceuticals, Navidea Biopharmaceuticals, RadioMedix, and AsherBio are some of the 15 competitors of Alpha-9 Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
